Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients

Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients

In this phase III, open-label, single-arm, multi-center 12-week study, we evaluated the efficacy and safety of combination therapy with sucroferric oxyhydroxide (PA21) and calcium carbonate for hemodialysis patients with hyperphosphatemia. Methods: We enrolled 35 subjects aged ≥ 20 years with end-st...

Full description

Bibliographic Details
Main Authors: Fumihiko Koiwa, Keitaro Yokoyama, Masafumi Fukagawa, Tadao Akizawa
Format: Article
Language:English
Published: Elsevier 2018-01-01
Series:Kidney International Reports
Subjects:
calcium carbonate
combination therapy
hemodialysis
hyperphosphatemia
sucroferric oxyhydroxide (PA21)
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917304059

Similar Items

Similar Items